The dataset presented here are part of the data planned to produce biodiesel from flaxseed. Biodiesel production from flaxseed oil through transesterification process using KOH as catalyst, and the operating parameters were optimized with the help of face-centered central composite design (FCCD) of response surface methodology (RSM). The operating independent variables selected such as, methanol oil ratio (4:1 to 6:1), catalyst (KOH) weight (0.40-1.0%), temperature (35 °C-65 °C), and reaction time (30 min-60 min) were optimized against biodiesel yield as response. The maximum yield (98.6%) of biodiesel from flaxseed can achieved at optimum methanol oil ratio (5.9:1), catalyst (KOH) weight (0.51%), reaction temperature (59.2 °C), and reaction time (33 min). The statistical significance of the data set was tested through the analysis of variance (ANOVA). These data were the part of the results reported in "Optimization of process variables for biodiesel production by transesterification of flaxseed oil and produced biodiesel characterizations" Renewable Energy [1].
The article Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update, written by [Shiv Sarin], was originally published electronically on the publisher's internet portal (currently SpringerLink) on June 06, 2019 without open access.
The first consensus report of the working party of the Asian Pacific Association for the Study of the Liver (APASL) set up in 2004 on acute-on-chronic liver failure (ACLF) was published in 2009. With international groups volunteering to join, the "APASL ACLF Research Consortium (AARC)" was formed in 2012, which continued to collect prospective ACLF patient data. Based on the prospective data analysis of nearly 1400 patients, the AARC consensus was published in 2014. In the past nearly four-and-a-half years, the AARC database has been enriched to about 5200 cases by major hepatology centers across Asia. The data published during the interim period were carefully analyzed and areas of contention and new developments in the field of ACLF were prioritized in a systematic manner. The AARC database was also approached for answering some of the issues where published data were limited, such as liver failure grading, its impact on the 'Golden Therapeutic Window', extrahepatic organ dysfunction and failure, development of sepsis, distinctive features of acute decompensation from ACLF and pediatric ACLF and the issues were analyzed. These initiatives concluded in a two-day meeting in October 2018 at New Delhi with finalization of the new AARC consensus. Only those statements, which were based on evidence using the Grade System and were unanimously recommended, were accepted. Finalized statements were again circulated to all the experts and subsequently presented at the AARC investigators meeting at the AASLD in November 2018. The suggestions from the experts were used to revise and finalize the consensus. After detailed deliberations and data analysis, the original definition of ACLF was found to withstand the test of time and be able to identify a homogenous group of patients presenting with liver failure. New management options including the algorithms for the management of coagulation disorders, renal replacement therapy, sepsis, variceal bleed, antivirals and criteria for liver transplantation for ACLF patients were proposed. The final consensus statements along with the relevant background information and areas requiring future studies are presented here.